High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying

Anatoly Severin1, Keiko Tabei, Fred Tenover

  • 1The Rockefeller University, New York, New York 10021, USA.

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) strains expressing vancomycin resistance (VRSA) were studied. VanA expression in S. aureus alters peptidoglycan synthesis, and mecA and vanA resistance mechanisms operate independently.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • First identification of methicillin-resistant Staphylococcus aureus (MRSA) with the enterococcal vanA gene complex and high-level vancomycin resistance (VRSA) in clinical settings.
  • Existing knowledge of MRSA's mecA-based resistance targeting cell wall biosynthesis.
  • Need to understand vanA expression in S. aureus and its interaction with mecA.

Purpose of the Study:

  • To investigate the expression of the vanA gene in the heterologous S. aureus background.
  • To determine how vanA interacts with the existing mecA-based resistance mechanism in S. aureus.
  • To elucidate the impact of combined vanA and mecA resistance on cell wall biosynthesis.

Main Methods:

  • Transfer of the vanA-containing staphylococcal plasmid from a clinical VRSA strain (HIP11714) to an MRSA strain (COL).
  • Characterization of the resulting transconjugant (COLVA) for antibiotic resistance profiles.
  • Analysis of peptidoglycan structure and cell wall precursor pools in COLVA.
  • Experimental inactivation of the mecA gene in COLVA to assess its effect on vancomycin resistance.

Main Results:

  • The transconjugant COLVA exhibited high and homogeneous resistance to both oxacillin and vancomycin.
  • Vancomycin exposure in COLVA led to abnormal peptidoglycan, with pentapeptides replaced by tetrapeptides and altered branching.
  • Key cell wall precursors shifted from UDP-MurNAc-pentapeptide to UDP-MurNAc-depsipeptide and UDP-MurNAc-tetrapeptide.
  • Transposon inactivation of mecA abolished beta-lactam resistance but did not affect vancomycin resistance.

Conclusions:

  • The vanA gene complex can be effectively expressed in S. aureus, conferring high-level vancomycin resistance.
  • Combined expression of vanA and mecA in S. aureus results in distinct alterations to cell wall peptidoglycan synthesis.
  • The mecA and vanA antibiotic resistance mechanisms in S. aureus appear to utilize separate enzymatic pathways for cell wall assembly.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...